NCT02820168

Brief Summary

The purpose of this study is to create a human-readable and executable computer language to implement medical prescriptions and to evaluate and refine this language, with the goal of improving safety and efficacy of patient care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 30, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2019

Completed
Last Updated

February 12, 2019

Status Verified

February 1, 2019

Enrollment Period

3 years

First QC Date

May 16, 2016

Last Update Submit

February 8, 2019

Conditions

PatientsProgramming Languages

Keywords

DesigningPatient-OrientedPrescriptions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Differences between Ideal and Actual Performance of Prescriptions by Number of Deviations between Sequences of Events

    Investigators will express the intent of prescriptions in prescription programming language. Investigators will then compare the actual performance of the prescription in a clinical environment to the performance of the prescription in a simulated environment based on the same inputs as occurred in the real clinical environment.

    2 years

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients seen at Northwestern Memorial Hospital and Northwestern Medicine Clinics

You may qualify if:

  • Patients between the ages of 18 and 50 years old who receive care at the Northwestern Maternal Fetal Medicine Clinic (MFM)
  • Patients between the ages of 18 and 50 years old who visit Northwestern Medicine outpatient facilities and are patients of a clinician who is a coinvestigator on this project.
  • Patients who are between the ages of 18 and 50 years old, are hospitalized at Northwestern Medicine inpatient facilities, and are patients of a clinician who is a coinvestigator on this project.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Northwestern Medicine Clinics

Chicago, Illinois, 60611, United States

Location

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Language

Condition Hierarchy (Ancestors)

CommunicationBehavior

Study Officials

  • Steven M Belknap, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor, Dermatology

Study Record Dates

First Submitted

May 16, 2016

First Posted

June 30, 2016

Study Start

February 1, 2016

Primary Completion

January 17, 2019

Study Completion

January 17, 2019

Last Updated

February 12, 2019

Record last verified: 2019-02

Locations

US(2)